Notoginsenoside Ft1

CAS No. 155683-00-4

Notoginsenoside Ft1 ( —— )

Catalog No. M20544 CAS No. 155683-00-4

Notoginsenoside Ft1 is a saponin originally isolated from P. notoginseng with diverse biological activities.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 45 In Stock
5MG 69 In Stock
10MG 88 In Stock
25MG 133 In Stock
50MG 200 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Notoginsenoside Ft1
  • Note
    Research use only not for human use.
  • Brief Description
    Notoginsenoside Ft1 is a saponin originally isolated from P. notoginseng with diverse biological activities.
  • Description
    Notoginsenoside Ft1 is a saponin originally isolated from P. notoginseng with diverse biological activities
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    155683-00-4
  • Formula Weight
    917.13
  • Molecular Formula
    C47H80O17
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:6.67 mg/mL (7.27 mM)
  • SMILES
    CC(C)=CCCC(C)(O)C1CCC2(C)C1C(O)CC1C3(C)CCC(OC4OC(CO)C(O)C(O)C4OC4OC(CO)C(O)C(O)C4OC4OCC(O)C(O)C4O)C(C)(C)C3CCC21C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Shen K Ji L Gong C et al. Notoginsenoside Ft1 promotes angiogenesis via HIF-1α mediated VEGF secretion and the regulation of PI3K/AKT and Raf/MEK/ERK signaling pathways[J]. Biochemical Pharmacology 2012 84(6).
molnova catalog
related products
  • MSDC 0602

    MSDC-0602 is an insulin sensitizer potentially for the treatment of diabetes.

  • Protocatechuic acid ...

    The herbs of Gastrodia elata BL.

  • Morellic acid

    Morellic acid has anti-cancer activity, it strongly inhibited the migration of HUVEC at a low concentration of 0.5 μM in HUVEC cell migration assay in vitro. Morellic acid also has antiangiogenic activity.